Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Prescription Drug User Fee Act (PDUFA)

Aquestive Works with FDA to Resolve Hurdles for its New Sublingual...

FDA Won’t Require Advisory Committee Meeting for Aquestive’s Sublingual Epinephrine

FDA Sets January 31, 2026 Target Date for Anaphylm™ Sublingual Epinephrine

OptumRx, Cigna Healthcare and Navitus Health Systems add neffy® Coverage to...

FDA Accepts neffy® Filing for Child Dose, Sets March 6 for...

ARS Completes Repeat Dosing Study of Nasal Epinephrine Required by FDA...

100% of Pediatric Patients with OFC Induced Anaphylaxis Responded to Single...

FDA Delays Approval of neffy™ Intranasal Epinephrine Until September

FDA Schedules Review of neffy®, an Intranasal Alternative to Epinephrine Auto-Injectors

FDA Accepts New Drug Application for Nasal Epinephrine Spray Treatment for...

Follow Us

Your School On Our Map

Put Your School on the Map